INVO Fertility (IVF) Income from Continuing Operations (2011 - 2026)
INVO Fertility (IVF) posted quarterly Income from Continuing Operations of 1747819.0 for Q1 2026, up 89.96% year-over-year from 920112.33 in Q1 2025, and up 33.91% quarter-over-quarter from 2644625.0 in Q3 2025.
INVO Fertility (IVF) Income from Continuing Operations (2011 - 2026) Analysis & Trends
INVO Fertility (IVF) has reported Income from Continuing Operations for 16 consecutive years, with 1747819.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Income from Continuing Operations rose 89.96% year-over-year to 1747819.0; the TTM figure through Mar 2026 stood at 25005124.0 (changed 0.07% YoY), while the FY2024 annual figure was 9214629.0, down 15.11% from the prior year.
- Income from Continuing Operations advanced to 1747819.0 in Q1 2026 per IVF's latest filing, from 2644625.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 1248440.0 in Q3 2023 and bottomed at 17403586.0 in Q1 2025.
- Historically, Income from Continuing Operations has averaged 3330699.25 across 5 years, with a median of 2550251.0 in 2022.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations plunged 2818.28% — and 2026, when it surged 89.96%.
- INVO Fertility's Income from Continuing Operations stood at 2766721.0 in 2022, then rose by 28.98% to 1965047.0 in 2023, then slumped by 90.44% to 3742284.0 in 2024, then rose by 29.33% to 2644625.0 in 2025, then soared by 33.91% to 1747819.0 in 2026.
- Business Quant data shows IVF's Income from Continuing Operations at 1747819.0 in Q1 2026, 2644625.0 in Q3 2025, and 3209094.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 201.00 Mn |
| 10 | INVO Fertility | 2.47 Mn | 2.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.75 Mn |
| Sep 30, 2025 | -2.64 Mn |
| Jun 30, 2025 | -3.21 Mn |
| Mar 31, 2025 | -17.40 Mn |
| Dec 31, 2024 | -3.74 Mn |
| Sep 30, 2024 | -1.63 Mn |
| Jun 30, 2024 | -2.25 Mn |
| Mar 31, 2024 | -1.60 Mn |
| Dec 31, 2023 | -1.97 Mn |
| Sep 30, 2023 | -1.25 Mn |
| Jun 30, 2023 | -2.24 Mn |
| Mar 31, 2023 | -2.55 Mn |
| Dec 31, 2022 | -2.77 Mn |
| Sep 30, 2022 | -2.55 Mn |
| Jun 30, 2022 | -2.80 Mn |
| Mar 31, 2022 | -2.95 Mn |
| Dec 31, 2021 | 101,782.00 |
| Sep 30, 2021 | -2.48 Mn |
| Jun 30, 2021 | -1.82 Mn |
| Mar 31, 2021 | -2.45 Mn |